GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Synageva BioPharma Corp's sale of investment for the three months ended in Dec. 2014 was $140.50 Mil. It means Synageva BioPharma Corp gained $140.50 Mil from selling investments. Synageva BioPharma Corp's sale of investment for the trailing twelve months (TTM) ended in Dec. 2014 was $486.70 Mil.
Compared with last quarter ($160.50 Mil in Sep. 2014 ), Synageva BioPharma Corp gained less money from selling investments in Dec. 2014 ($140.50 Mil).
Sale of Investments represents cash inflow on the sale of investments in securities.
Synageva BioPharma Corp SaleOfInvestment for the trailing twelve months (TTM) ended in Dec. 2014 was 90.65 (Mar. 2014 ) + 95.05 (Jun. 2014 ) + 160.5 (Sep. 2014 ) + 140.5 (Dec. 2014 ) = $486.70 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Synageva BioPharma Corp Annual Data
Synageva BioPharma Corp Quarterly Data